ZimVie Inc. (NASDAQ:ZIMV) Sees Significant Growth in Short Interest

ZimVie Inc. (NASDAQ:ZIMV) was the recipient of a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 400,500 shares, a growth of 16.5% from the February 13th total of 343,900 shares. Based on an average daily volume of 126,700 shares, the days-to-cover ratio is presently 3.2 days. Currently, 1.5% of the company’s shares are sold short.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. SG Americas Securities LLC increased its position in shares of ZimVie by 15.7% in the fourth quarter. SG Americas Securities LLC now owns 11,110 shares of the company’s stock worth $155,000 after acquiring an additional 1,508 shares in the last quarter. EMC Capital Management boosted its position in ZimVie by 47.0% during the 4th quarter. EMC Capital Management now owns 13,802 shares of the company’s stock worth $193,000 after purchasing an additional 4,414 shares during the period. Wealth Enhancement Advisory Services LLC increased its holdings in ZimVie by 5.8% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 15,127 shares of the company’s stock valued at $211,000 after purchasing an additional 836 shares in the last quarter. Wells Fargo & Company MN raised its position in ZimVie by 17.8% in the fourth quarter. Wells Fargo & Company MN now owns 17,037 shares of the company’s stock valued at $238,000 after purchasing an additional 2,569 shares during the period. Finally, Integrated Quantitative Investments LLC purchased a new position in ZimVie in the fourth quarter valued at about $248,000. 95.63% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Needham & Company LLC reiterated a “hold” rating on shares of ZimVie in a research report on Thursday, March 13th.

ZimVie Stock Performance

NASDAQ:ZIMV opened at $11.60 on Friday. The company has a market cap of $321.05 million, a P/E ratio of -0.88 and a beta of 2.10. The firm’s 50 day moving average is $13.35 and its two-hundred day moving average is $14.28. ZimVie has a fifty-two week low of $11.54 and a fifty-two week high of $22.40. The company has a quick ratio of 1.38, a current ratio of 1.94 and a debt-to-equity ratio of 0.57.

ZimVie (NASDAQ:ZIMV) last issued its earnings results on Wednesday, February 26th. The company reported $0.27 earnings per share for the quarter, beating analysts’ consensus estimates of $0.25 by $0.02. The firm had revenue of $111.52 million for the quarter, compared to analysts’ expectations of $113.67 million. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. Analysts expect that ZimVie will post 0.6 EPS for the current year.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.